Concepedia
Statistics
Publications
37
Citations
3.2K
H-Index
29
Active since
2001
Affiliations
Granta Design (United Kingdom)(Current)
Institute of Cancer Research
Cancer Research UK
Novartis (Switzerland)
The Open University
Andrew J. Massey is an author at Granta Design (United Kingdom) specializing in pharmacology, drug discovery, and oncology.
Publications per year
2001–2021
4,5-Diarylisoxazole Hsp90 Chaperone Inhibitors: Potential Therapeutic Agents for the Treatment of Cancer
Paul A. Brough, Wynne Aherne, Xavier Barril et al. · Journal of Medicinal Chemistry · 2007 · 445 citations · Full text
Medicine, Medicinal Chemistry, Pharmacology +11
A novel, small molecule inhibitor of Hsc70/Hsp70 potentiates Hsp90 inhibitor induced apoptosis in HCT116 colon carcinoma cells
Andrew J. Massey, D.S. Williamson, Helen Browne et al. · Cancer Chemotherapy and Pharmacology · 2009 · 329 citations · Full text
Medicine, Oncology, Pharmacology +16
Novel, Potent Small-Molecule Inhibitors of the Molecular Chaperone Hsp90 Discovered through Structure-Based Design
Brian Dymock, Xavier Barril, Paul A. Brough et al. · Journal of Medicinal Chemistry · 2005 · 231 citations · Full text
Pharmacy, Medicinal Chemistry, Pharmacology +15
Novel Adenosine-Derived Inhibitors of 70 kDa Heat Shock Protein, Discovered Through Structure-Based Design
D.S. Williamson, Jenifer Borgognoni, Alexandra Clay et al. · Journal of Medicinal Chemistry · 2009 · 229 citations · Full text
Pharmacy, Medicinal Chemistry, Pharmacology +14
NVP-AUY922: a small molecule HSP90 inhibitor with potent antitumor activity in preclinical breast cancer models
Michael Rugaard Jensen, Joseph Schoepfer, Thomas Radimerski et al. · Breast Cancer Research · 2008 · 225 citations · Full text
Medicine, Oncology, Pharmacology +13
1–5 of 37